Veradermics Announces Two Poster Presentations on VDPHL01 at the 2026 Music City SCALE Symposium
Veradermics will present two E-posters on VDPHL01, its investigational extended-release oral minoxidil tablet, at the 2026 Music City SCALE Symposium in Nashville. The first poster is a blinded, retrospective investigator global assessment comparing VDPHL01's efficacy in males at 2 and 4 months against 6-month data for immediate-release oral minoxidil and topical minoxidil. The second poster uses the AI-based Global HairMap™ platform to compare androgenetic alopecia outcomes of VDPHL01 at 4 months against 6 months of immediate-release oral minoxidil treatment.
Key figures
- Drug Name
- VDPHL01 (extended-release minoxidil tablet)
- Phase Of Trial
- Phase 2
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.